Showing results (971-980 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|January 22, 2014
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomesJ Dziuba, P Alperin, J Racketa, et al.
Diabetes, Obesity & Metabolism|January 22, 2014
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)C Mathieu, H W Rodbard, B Cariou, et al.
Diabetes, Obesity & Metabolism|January 23, 2014
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-inferiority trialK Kobayashi, H Yokoh, Y Sato, et al.
Diabetes, Obesity & Metabolism|June 13, 2014
Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cellsB M Moran, Y H A Abdel-Wahab, P R Flatt, et al.
Diabetes, Obesity & Metabolism|August 14, 2012
Insulin aspart has a shorter duration of action than human insulin over a wide dose-rangeL Nosek, K Roggen, L Heinemann, et al.
Diabetes, Obesity & Metabolism|August 14, 2012
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in manS J Busch, P Hoffmann, P Sahota, et al.
Diabetes, Obesity & Metabolism|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trialsAmy Kang, Brendan Smyth, Brendon L Neuen, et al.
Diabetes, Obesity & Metabolism|May 15, 2023
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetesHeidi J Silver, Dianna Olson, Dustin Mayfield, et al.
Diabetes, Obesity & Metabolism|May 19, 2023
Altered high-density lipoprotein composition is associated with risk for complications in type 2 diabetes mellitus in South Asian descendants: A cross-sectional, case-control study on lipoprotein subclass profilingLushun Yuan, Ruifang Li-Gao, Aswin Verhoeven, et al.
Diabetes, Obesity & Metabolism|May 19, 2023
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational studyPer G Hagelqvist, Andreas Andersen, Kaisar Maytham, et al.
Pageof 632